Maternal preferences for infant respiratory syncytial virus (RSV) preventives: an Australian discrete choice experiment

Abstract

Objectives: Two RSV preventatives, a maternal RSV vaccine and a long-acting monoclonal antibody, were introduced in Australia in 2025. In the year prior to program introduction, we explored maternal acceptability, preferences, awareness and knowledge of disease and provider delivery preferences. Design: Discrete Choice Experiment (DCE). Setting: Qualitative data from online focus groups informed a national DCE survey. Participants: Qualitative data from Australian mothers with a child <2 years was collected through focus groups, identifying key themes for decision-making. The final attributes for the DCE survey included effectiveness, cost, safety, timing, and risk perception of the disease ..